Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | FTRE | LCII |
|---|---|---|
| Price | $21.11 | $82.58 |
| Change today | ▲ 5.55% | ▼ 0.28% |
| Market cap | $2.01B | $2.01B |
| Return, 3 months | +20.8% | -21.1% |
| Return, year to date | +22.4% | -29.8% |
| Return, 1 year | +120.1% | -4.6% |
| P/E (TTM) | -25.4 | 9.6 |
| P/B | 3.8 | 1.4 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | – | 5.57% |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | +8.1% | +48.5% |
| Analyst buy share | 56% | 50% |
| RSI (14) | 64 | 30 |
| 30-day volatility | 53.1% | 27.3% |
| Max drawdown, 1 year | -51.8% | -46.1% |
| Trend read | Strong uptrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.